Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Good response to pulsed dye laser in patients with capillary malformation-arteriovenous malformation syndrome (CM-AVM).

Iznardo H, Roé E, Puig L, Vikula M, López-Sánchez C, Baselga E.

Pediatr Dermatol. 2020 Jan 15. doi: 10.1111/pde.14095. [Epub ahead of print]

PMID:
31944370
2.

Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.

Olsen GM, Hansen LM, Stefanko NS, Mathes E, Puttgen KB, Tollefson MM, Lauren C, Mancini AJ, McCuaig CC, Frieden IJ, Adams D, Baselga E, Chamlin S, Gupta D, Frommelt P, Garzon MC, Horii K, Klajn J, Maheshwari M, Newell B, Nguyen HL, Nopper A, Powell J, Siegel DH, Drolet BA.

JAMA Dermatol. 2019 Dec 11. doi: 10.1001/jamadermatol.2019.3839. [Epub ahead of print]

PMID:
31825455
3.

Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.

Flores-Climente V, Rozas-Muñoz E, Martínez-Grau A, Aucouturier F, Luna S, Baselga E.

Pediatr Dermatol. 2019 Nov;36(6):984-985. doi: 10.1111/pde.13971. Epub 2019 Aug 25.

PMID:
31448438
4.

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

Bosma AL, Spuls PI, Garcia-Doval I, Naldi L, Prieto-Merino D, Tesch F, Apfelbacher CJ, Arents BWM, Barbarot S, Baselga E, Deleuran M, Eichenfield LF, Gerbens LAA, Irvine AD, Manca A, Mendes-Bastos P, Middelkamp-Hup MA, Roberts A, Seneschal J, Svensson Å, Thyssen JP, Torres T, Vermeulen FM, Vestergaard C, von Kobyletzki LB, Wall D, Weidinger S, Schmitt J, Flohr C.

Br J Dermatol. 2019 Aug 24. doi: 10.1111/bjd.18452. [Epub ahead of print]

PMID:
31444799
5.

PIK3CA mutations in vascular malformations.

Castillo SD, Baselga E, Graupera M.

Curr Opin Hematol. 2019 May;26(3):170-178. doi: 10.1097/MOH.0000000000000496.

PMID:
30855339
6.

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses.

Chacón-Solano E, León C, Díaz F, García-García F, García M, Escámez MJ, Guerrero-Aspizua S, Conti CJ, Mencía Á, Martínez-Santamaría L, Llames S, Pévida M, Carbonell-Caballero J, Puig-Butillé JA, Maseda R, Puig S, de Lucas R, Baselga E, Larcher F, Dopazo J, Del Río M.

Br J Dermatol. 2019 Sep;181(3):512-522. doi: 10.1111/bjd.17698. Epub 2019 Apr 15.

7.

Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments.

Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo-Hernandez H, Arevalo-Rodriguez I.

Br J Dermatol. 2019 Mar;180(3):527-533. doi: 10.1111/bjd.17407. Epub 2018 Dec 19. Review.

PMID:
30414269
8.

A novel vascular tumour characterized by coexisting HRAS and GNAQ activating mutations.

Castel P, Bagué S, Granell E, Guerrero Vara R, Baselga J, Baselga E.

Br J Dermatol. 2019 Apr;180(4):927-928. doi: 10.1111/bjd.17393. Epub 2018 Dec 13. No abstract available.

PMID:
30387498
9.

Congenital tufted angioma: A multicenter retrospective study of 30 cases.

Feito-Rodríguez M, Sánchez-Orta A, De Lucas R, López-Gutiérrez JC, Ruiz-Bravo E, Baselga E, Victoria AM, Hernández-Martín A, Campos-Domínguez M, Berenguer Fröhner B, Garnacho-Saucedo G, Vera Casaño A, Vicente Villa A, Bernabeu-Wittel J, Kutzner H, Requena L.

Pediatr Dermatol. 2018 Nov;35(6):808-816. doi: 10.1111/pde.13683. Epub 2018 Oct 15.

PMID:
30318642
10.

Late growth of infantile hemangiomas in children >3 years of age: A retrospective study.

O'Brien KF, Shah SD, Pope E, Phillips RJ, Blei F, Baselga E, Garzon MC, McCuaig C, Haggstrom AN, Hoeger PH, Treat JR, Perman MJ, Bellet JS, Cubiró X, Poole J, Frieden IJ.

J Am Acad Dermatol. 2019 Feb;80(2):493-499. doi: 10.1016/j.jaad.2018.07.061. Epub 2018 Oct 5.

PMID:
30293898
11.

Localized infantile hemangiomas of the face and scalp: Predilection for the midline and periorbital and perioral skin.

Haggstrom AN, Baselga E, Chamlin SL, Drolet BA, Garzon MC, Holland KE, Horii KA, Lauren C, Lucky A, Mancini AJ, Mathes E, McCuaig CC, Morel K, Newell B, Pope E, Powell J, Puttgen K, Rahnama-Moghadam S, Song W, Frieden IJ.

Pediatr Dermatol. 2018 Nov;35(6):774-779. doi: 10.1111/pde.13626. Epub 2018 Aug 31.

PMID:
30168172
12.

Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.

Baselga E, Dembowska-Baginska B, Przewratil P, González-Enseñat MA, Wyrzykowski D, Torrelo A, López Gutiérrez JC, Rychłowska-Pruszyńska M, de Lucas-Laguna R, Esteve-Martinez A, Roé E, Zaim M, Menon Y, Gautier S, Lebbé G, Bouroubi A, Delarue A, Voisard JJ.

Pediatrics. 2018 Sep;142(3). pii: e20173866. doi: 10.1542/peds.2017-3866. Epub 2018 Aug 6.

13.

Lower lip capillary malformation associated with lymphatic malformation without overgrowth: Part of the spectrum of CLAPO syndrome.

Downey C, López-Gutiérrez JC, Roé-Crespo E, Puig L, Baselga E.

Pediatr Dermatol. 2018 Jul;35(4):e243-e244. doi: 10.1111/pde.13514. Epub 2018 May 15.

PMID:
29766551
14.

Interventions for infantile haemangiomas of the skin.

Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo-Hernandez H, Arevalo-Rodriguez I.

Cochrane Database Syst Rev. 2018 Apr 18;4:CD006545. doi: 10.1002/14651858.CD006545.pub3. Review.

15.

Fern-shaped patch as a hallmark of blue rubber bleb nevus syndrome in neonatal venous malformations.

Ivars M, Martin-Santiago A, Baselga E, Guibaud L, López-Gutiérrez JC.

Eur J Pediatr. 2018 Sep;177(9):1395-1398. doi: 10.1007/s00431-018-3126-x. Epub 2018 Mar 8.

PMID:
29520504
16.

Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics.

Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA.

J Invest Dermatol. 2018 Apr;138(4):957-967. doi: 10.1016/j.jid.2017.10.033. Epub 2017 Nov 22.

17.

Infantile hemangiomas with conjunctival involvement: An underreported occurrence.

Theiler M, Baselga E, Gerth-Kahlert C, Mathes EF, Schwieger-Briel A, Chaloupka K, Weibel L, Frieden IJ.

Pediatr Dermatol. 2017 Nov;34(6):681-685. doi: 10.1111/pde.13305.

PMID:
29144051
18.

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS; Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP).

JAMA Dermatol. 2017 Nov 1;153(11):1147-1157. doi: 10.1001/jamadermatol.2017.3029.

19.

Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.

Wan J, Steiner J, Baselga E, Blei F, Cordisco M, Garzon MC, Goddard DS, Haggstrom A, Krol A, Frieden IJ, Metry D, Morel KD, Verhagen JMA, Wargon O, Drolet BA, Siegel DH.

J Pediatr. 2017 Nov;190:275-279. doi: 10.1016/j.jpeds.2017.06.055. Epub 2017 Sep 1.

20.

Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.

Amyere M, Revencu N, Helaers R, Pairet E, Baselga E, Cordisco M, Chung W, Dubois J, Lacour JP, Martorell L, Mazereeuw-Hautier J, Pyeritz RE, Amor DJ, Bisdorff A, Blei F, Bombei H, Dompmartin A, Brooks D, Dupont J, González-Enseñat MA, Frieden I, Gérard M, Kvarnung M, Hanson-Kahn AK, Hudgins L, Léauté-Labrèze C, McCuaig C, Metry D, Parent P, Paul C, Petit F, Phan A, Quere I, Salhi A, Turner A, Vabres P, Vicente A, Wargon O, Watanabe S, Weibel L, Wilson A, Willing M, Mulliken JB, Boon LM, Vikkula M.

Circulation. 2017 Sep 12;136(11):1037-1048. doi: 10.1161/CIRCULATIONAHA.116.026886. Epub 2017 Jul 7.

PMID:
28687708
21.

Microcystic Lymphatic Malformation Successfully Treated With Topical Rapamycin.

García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E.

Pediatrics. 2017 May;139(5). pii: e20162105. doi: 10.1542/peds.2016-2105. Epub 2017 Apr 12.

22.

Investigation of a suspected outbreak of lipoatrophia semicircularis in children.

Rius C, Baselga E, Tizón J, Fuentes P, Muñoz-Garza FZ, Roigé G, Llebaria X, Caylà JA; en nombre del grupo de trabajo.

Med Clin (Barc). 2017 Aug 10;149(3):101-106. doi: 10.1016/j.medcli.2017.01.032. Epub 2017 Apr 10. English, Spanish.

PMID:
28408109
23.

Sturge-Weber Syndrome: A Review.

Higueros E, Roe E, Granell E, Baselga E.

Actas Dermosifiliogr. 2017 Jun;108(5):407-417. doi: 10.1016/j.ad.2016.09.022. Epub 2017 Jan 23. Review. English, Spanish.

PMID:
28126187
24.

Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment.

Mull JL, Chamlin SL, Lai JS, Beaumont JL, Cella D, Rancour EA, Baselga E, Haggstrom AN.

Pediatr Dermatol. 2017 Jan;34(1):78-83. doi: 10.1111/pde.13032. Epub 2016 Dec 16.

PMID:
27981617
25.

Congenital Plaque-type Glomuvenous Malformation: 11 Years of Follow-up and Response to Treatment With the Combined Pulsed-Dye and Neodymium:Yttrium-Aluminum-Garnet Laser.

Vargas-Navia N, Baselga E, Muñoz-Garza FZ, Puig L.

Actas Dermosifiliogr. 2017 Jan - Feb;108(1):72-74. doi: 10.1016/j.ad.2016.07.008. Epub 2016 Aug 21. Review. English, Spanish. No abstract available.

PMID:
27555518
26.

Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.

Baselga E, Roe E, Coulie J, Muñoz FZ, Boon LM, McCuaig C, Hernandez-Martín A, Gich I, Puig L.

JAMA Dermatol. 2016 Nov 1;152(11):1239-1243. doi: 10.1001/jamadermatol.2016.2905.

PMID:
27540637
27.

Topical Timolol Maleate Treatment of Infantile Hemangiomas.

Püttgen K, Lucky A, Adams D, Pope E, McCuaig C, Powell J, Feigenbaum D, Savva Y, Baselga E, Holland K, Drolet B, Siegel D, Morel KD, Garzon MC, Mathes E, Lauren C, Nopper A, Horii K, Newell B, Song W, Frieden I; Hemangioma Investigator Group.

Pediatrics. 2016 Sep;138(3). pii: e20160355. doi: 10.1542/peds.2016-0355. Epub 2016 Aug 15.

28.

Vascular Stains: Proposal for a Clinical Classification to Improve Diagnosis and Management.

Rozas-Muñoz E, Frieden IJ, Roé E, Puig L, Baselga E.

Pediatr Dermatol. 2016 Nov;33(6):570-584. doi: 10.1111/pde.12939. Epub 2016 Jul 25. Review.

PMID:
27456075
29.

Agminated Fibroblastic Conective Tissue Nevus: A New Clinical Presentation.

Downey C, Requena L, Bagué S, Sánchez Martínez MÁ, Lloreta J, Baselga E.

Pediatr Dermatol. 2016 Jul;33(4):e240-3. doi: 10.1111/pde.12896. Epub 2016 Jun 14.

PMID:
27296971
30.

Somatic Embryonic FGFR2 Mutations in Keratinocytic Epidermal Nevi.

Toll A, Fernández LC, Pons T, Groesser L, Sagrera A, Carrillo-de Santa Pau E, Vicente A, Baselga E, Vázquez M, Beltrán S, Pisano DG, Rueda D, Gut M, Pujol RM, Hafner C, Gut I, Valencia A, Real FX.

J Invest Dermatol. 2016 Aug;136(8):1718-1721. doi: 10.1016/j.jid.2016.03.040. Epub 2016 Apr 19. No abstract available.

31.

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

Castel P, Carmona FJ, Grego-Bessa J, Berger MF, Viale A, Anderson KV, Bague S, Scaltriti M, Antonescu CR, Baselga E, Baselga J.

Sci Transl Med. 2016 Mar 30;8(332):332ra42. doi: 10.1126/scitranslmed.aaf1164.

32.

DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.

Starokadomskyy P, Gemelli T, Rios JJ, Xing C, Wang RC, Li H, Pokatayev V, Dozmorov I, Khan S, Miyata N, Fraile G, Raj P, Xu Z, Xu Z, Ma L, Lin Z, Wang H, Yang Y, Ben-Amitai D, Orenstein N, Mussaffi H, Baselga E, Tadini G, Grunebaum E, Sarajlija A, Krzewski K, Wakeland EK, Yan N, de la Morena MT, Zinn AR, Burstein E.

Nat Immunol. 2016 May;17(5):495-504. doi: 10.1038/ni.3409. Epub 2016 Mar 28.

33.

Rebound Growth of Infantile Hemangiomas After Propranolol Therapy.

Shah SD, Baselga E, McCuaig C, Pope E, Coulie J, Boon LM, Garzon MC, Haggstrom AN, Adams D, Drolet BA, Newell BD, Powell J, García-Romero MT, Chute C, Roe E, Siegel DH, Grimes B, Frieden IJ.

Pediatrics. 2016 Apr;137(4). pii: e20151754. doi: 10.1542/peds.2015-1754. Epub 2016 Mar 7.

34.

Infantile Hemangiomas in Twins: A Prospective Cohort Study.

Greco MF, Frieden IJ, Drolet BA, Garzon MC, Mancini AJ, Chamlin SL, Metry D, Adams D, Lucky A, Wentzel MS, Horii KA, Baselga E, McCuaig CC, Powell J, Haggstrom A, Siegel D, Morel KD, Cordisco MR, Nopper AJ, Krol A; Hemangioma Investigator Group.

Pediatr Dermatol. 2016 Mar-Apr;33(2):178-83. doi: 10.1111/pde.12781. Epub 2016 Feb 11.

PMID:
26863906
35.

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.

Wedgeworth E, Glover M, Irvine AD, Neri I, Baselga E, Clayton TH, Beattie PE, Bjerre JV, Burrows NP, Foelster-Holst R, Hedelund L, Hernandez-Martin A, Audrain H, Bhate K, Brown SJ, Baryschpolec S, Darne S, Durack A, Dvorakova V, Gach J, Goldstraw N, Goodyear H, Grabczynska S, Greenblatt D, Halpern J, Hearn RM, Hoey S, Hughes B, Jayaraj R, Johansson EK, Lam M, Leech S, O'Regan GM, Morrison D, Porter W, Ramesh R, Schill T, Shaw L, Taylor AE, Taylor R, Thomson J, Tiffin P, Tsakok M, Janmohamed SR, Laguda B, McPherson T, Oranje AP, Patrizi A, Ravenscroft JC, Shahidullah H, Solman L, Svensson A, Wahlgren CF, Hoeger PH, Flohr C.

Br J Dermatol. 2016 Mar;174(3):594-601. doi: 10.1111/bjd.14233. Epub 2015 Dec 26.

PMID:
26473312
36.

Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".

Marqués L, Núñez-Córdoba JM, Aguado L, Pretel M, Boixeda P, Nagore E, Baselga E, Redondo P.

J Am Acad Dermatol. 2015 Aug;73(2):e73-4. doi: 10.1016/j.jaad.2015.04.058. No abstract available.

PMID:
26184005
37.

Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies.

Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, Lord DJ, Mitchel S, Powell J, Prendiville J, Vikkula M; ISSVA Board and Scientific Committee.

Pediatrics. 2015 Jul;136(1):e203-14. doi: 10.1542/peds.2014-3673. Epub 2015 Jun 8. Review.

38.

Treatment of infantile haemangiomas: recommendations of a European expert group.

Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Ciofi Degli Atti M, El Hachem M, Oranje AP, Rubin AT, Weibel L, Léauté-Labrèze C.

Eur J Pediatr. 2015 Jul;174(7):855-65. doi: 10.1007/s00431-015-2570-0. Epub 2015 May 29. Review.

PMID:
26021855
39.

Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership.

Hernández-Martín A, Dávila-Seijo P, de Lucas R, Baselga E, Redondo P, Martín-Santiago A, Azaña-Defez JM, González-Viejo I, Jiménez-Ferreres L, González-Enseñat MA, Arroyo-Manzanal MI, Soria JM, Garcia-Doval I.

Br J Dermatol. 2015 Nov;173(5):1280-3. doi: 10.1111/bjd.13914. Epub 2015 Aug 12. No abstract available.

PMID:
25996448
40.

Hemangiomas and the eye.

Spence-Shishido AA, Good WV, Baselga E, Frieden IJ.

Clin Dermatol. 2015 Mar-Apr;33(2):170-82. doi: 10.1016/j.clindermatol.2014.10.009. Review.

PMID:
25704937
41.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ.

N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.

42.

Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.

Chamlin SL, Mancini AJ, Lai JS, Beaumont JL, Cella D, Adams D, Drolet B, Baselga E, Frieden IJ, Garzon M, Holland K, Horii KA, Lucky AW, McCuaig C, Metry D, Morel KD, Newell BD, Nopper AJ, Powell J, Siegel D, Haggstrom AN.

J Invest Dermatol. 2015 Jun;135(6):1533-1539. doi: 10.1038/jid.2015.18. Epub 2015 Jan 23.

43.

Oxidative stress and mitochondrial dysfunction in Kindler syndrome.

Zapatero-Solana E, García-Giménez JL, Guerrero-Aspizua S, García M, Toll A, Baselga E, Durán-Moreno M, Markovic J, García-Verdugo JM, Conti CJ, Has C, Larcher F, Pallardó FV, Del Rio M.

Orphanet J Rare Dis. 2014 Dec 21;9:211. doi: 10.1186/s13023-014-0211-8.

44.

Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.

Marqués L, Núñez-Córdoba JM, Aguado L, Pretel M, Boixeda P, Nagore E, Baselga E, Redondo P.

J Am Acad Dermatol. 2015 Jan;72(1):151-8.e1. doi: 10.1016/j.jaad.2014.10.011. Epub 2014 Nov 12.

PMID:
25455610
45.

The "biker-glove" pattern of segmental infantile hemangiomas on the hands and feet.

Weitz NA, Bayer ML, Baselga E, Torres M, Siegel D, Drolet BA, Frieden IJ, Haggstrom AN.

J Am Acad Dermatol. 2014 Sep;71(3):542-7. doi: 10.1016/j.jaad.2014.04.062. Epub 2014 Jun 11.

PMID:
24929885
46.

[Sock-line hyperpigmentation].

Novoa A, Baselga E.

An Pediatr (Barc). 2014 Dec;81(6):401-2. doi: 10.1016/j.anpedi.2013.12.005. Epub 2014 Jan 24. Spanish. No abstract available.

47.

Hyperpigmented macules on the face of young children: a series of 25 cases.

Hernández-Martín A, Gilliam AE, Baselga E, Vicente A, Lam J, González-Enseñat M, Azorín D, Torrelo A.

J Am Acad Dermatol. 2014 Feb;70(2):288-90. doi: 10.1016/j.jaad.2013.10.045. Epub 2013 Dec 15.

PMID:
24342755
48.

Pediatric cutaneous lupus erythematosus treated with pulsed dye laser.

Yélamos O, Roé E, Baselga E, Puig L.

Pediatr Dermatol. 2014 Jan-Feb;31(1):113-5. doi: 10.1111/pde.12248. Epub 2013 Nov 14.

PMID:
24224569
49.

Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Mendola A, Schlögel MJ, Ghalamkarpour A, Irrthum A, Nguyen HL, Fastré E, Bygum A, van der Vleuten C, Fagerberg C, Baselga E, Quere I, Mulliken JB, Boon LM, Brouillard P, Vikkula M; Lymphedema Research Group.

Mol Syndromol. 2013 Sep;4(6):257-66. doi: 10.1159/000354097. Epub 2013 Aug 21.

50.

RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation.

Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, Dompmartin A, Syed S, Martin-Santiago A, Ades L, Collins F, Smith J, Sandaradura S, Barrio VR, Burrows PE, Blei F, Cozzolino M, Brunetti-Pierri N, Vicente A, Abramowicz M, Désir J, Vilain C, Chung WK, Wilson A, Gardiner CA, Dwight Y, Lord DJ, Fishman L, Cytrynbaum C, Chamlin S, Ghali F, Gilaberte Y, Joss S, Boente Mdel C, Léauté-Labrèze C, Delrue MA, Bayliss S, Martorell L, González-Enseñat MA, Mazereeuw-Hautier J, O'Donnell B, Bessis D, Pyeritz RE, Salhi A, Tan OT, Wargon O, Mulliken JB, Vikkula M.

Hum Mutat. 2013 Dec;34(12):1632-41. doi: 10.1002/humu.22431. Epub 2013 Oct 10.

PMID:
24038909

Supplemental Content

Loading ...
Support Center